Health and Well-Being

In recent years, particularly after the pandemic, the demand for effective antibacterial and antiviral solutions has surged. These solutions are increasingly utilized in diverse settings, including residential spaces, educational institutions, public areas, and transportation systems. Thus, it is anticipated that the demand for antimicrobial and antiviral products will continue to grow. Despite their utility, traditional antimicrobial and antiviral technologies have notable limitations. Copper, for example, offers a strong immediate antimicrobial effect but suffers from reduced durability due to oxidation and is effective only within a limited range. Silver ions are more durable and applicable to a wider range of surfaces but lack the immediate efficacy of copper. Photocatalysts, while more durable than both copper and silver, are heavily dependent on the availability of a suitable light source. These challenges underscore the need for a technology that is fast-acting, durable, and versatile across various environments. To address these challenges, the technology owner has developed a hybrid photocatalytic film with enhanced antibacterial and antiviral properties. This solution combines the photocatalytic activity of copper suboxide and titanium dioxide with visible light responsiveness to effectively denature membrane proteins on virus surfaces, thereby reducing their infectivity.  Additionally, the technology incorporates a film-based manufacturing process, providing a more efficient alternative to traditional paint-based approaches. The technology owner is actively seeking R&D collaborations and licensing opportunities with industry partners interested in implementing this film in various applications.

Glaucoma stands as the leading cause of irreversible blindness worldwide after cataract. It is expected to affect 111.8 million people by 2040 [1], exacerbates by the aging population globally. Despite its prevalence, 50% of people with glaucoma are undiagnosed. Current methods of imaging the iridocorneal angle for glaucoma diagnosis are severely limited by cost and utility, with traditional gonioscopy being the main method. Gonioscopy is a subjective procedure and the method causes discomfort in patients. This technology is a compact, handheld device specifically designed to enhance the accessibility of glaucoma diagnosis. With its portable and user-friendly design, it enables the evaluation and automated diagnosis of glaucoma angle, making it suitable for use by non-specialists. The device is complemented by advanced image processing and management software, which facilitates precise and automated angle evaluation, ensuring accurate and efficient diagnostics. The technology owner seeks collaboration with partners interested in development and licensing opportunities. Medical device manufacturers, technology firms, or individuals passionate about advancing innovative healthcare solutions are invited to collaborate or license the technology. Partnerships can focus on optimizing the design, scaling production, and facilitating successful market entry. [1] Tham, Y., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. (2014). Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology, 121(11), 2081–2090. https://doi.org/10.1016/j.ophtha.2014.05.013

Patients recovering from brain injuries or neurological disorders often experience a plateau in recovery within 6-12 months, even though they haven't fully regained their abilities. Similarly, athletes face stagnation in their performance or increased risk of injury when pushing to new levels. These challenges stem from underlying maladaptive neuro-muscular patterns that are not adequately addressed by conventional methods. This neuro-integrative wearable technology provides a breakthrough solution by giving users an “inside view” of their brain and muscle responses in real-time as they perform tasks. By monitoring these responses, the system helps users to self-correct maladaptive behaviors that are limiting their recovery or performance. This process allows users to break through recovery plateaus or avoid performance stagnation by training both brain and muscle function in unison. Beyond aiding in recovery, this wearable is also suitable for new patients and novice athletes seeking a faster track to recovery or peak performance without relying on traditional trial-and-error methods. The technology can be applied across various populations—children, adults, and the elderly—to help improve recovery from disabilities, enhance learning, boost performance, or even slow down the natural decline in abilities with age. The device is portable, easy to use, and adaptable for a variety of settings including hospitals, schools, nursing homes, and home environments. Its potential applications are expanding, with uses in stress disorder prevention, injury prevention, and improving self-regulation in children and adults with special needs. The tech owner is seeking collaboration with: Rehabilitation facilities offering neurorehabilitation for stroke and brain injury recovery. Sports performance centers aiming to prevent injuries and optimize athlete performance. Educational institutions focused on enhancing cognitive, physical and learning development.

Collagen is the body's most abundant protein, making up 25-35% of all proteins. It's a vital component of connective tissues in skin, bones, tendons, ligaments, and cartilage. Primarily composed of amino acids—30% glycine, 20% proline, and 10% hydroxyproline—collagen's unique triple-helix structure delivers exceptional strength, elasticity, and flexibility. It supports skin, nail, and hair health, boosts bone density, reduces osteoporosis risk, and enhances gut health. Common sources of collagen include meat, bone broth, fish, gelatin, and dairy. However, traditional collagen products often rely on animal or marine sources, using harsh chemical extraction methods that risk contamination, pose health hazards, and contribute to environmental destruction through waste and animal cruelty. This plant-based collagen precursor powder offers a clean, functional, sustainable, eco-friendly alternative (no e number ingredients). The formulation is enriched with amino acids, vitamins, and antioxidants, vital for collagen synthesis and stability, supporting muscle structure, and reducing collagen breakdown. Rigorously tested for functionality and safety, it avoids harmful chemicals and animal exploitation, significantly reducing environmental impact. The technology owner seeks to work with the OEMs of FMCG/CPGs to incorporate the functional blend in varied foods.

In the wake of the COVID-19 pandemic, people have developed new expectations for indoor air quality. It is no longer just about ventilation and purification, but also about providing clean and safe air for a healthier environment. Traditional UVC technology (254 nm) has been widely used in HVAC systems and air purifiers to disinfect airborne pathogens. To ensure its effectiveness, sufficient contact time is required, hence it is often used in unoccupied spaces due to safety concerns.  This solution utilises human-safe 222 nm far-UVC technology which has been shown to be able to effectively inactivate airborne pathogens while maintaining safety since it does not penetrate the outer layer of human skin or eyes. This allows for continuous disinfection of air in occupied spaces. By integrating 222 nm far-UVC technology into HVAC system, including air purification, air monitoring and IoT management platforms, the company offers a complete solution for clean and safe air. With integrated capabilities in both R&D and manufacturing, the company can provide tailor-made solutions for different industry applications. They are seeking collaborations with real estate developers, chain restaurant operators and pathogenic air sampling technology experts to further develop and commercialise this solution.

Superoxide dismutase (SOD) is a key antioxidant enzyme that protects cells from oxidative stress by catalysing the conversion of superoxide radicals into less harmful molecules like oxygen and hydrogen peroxide. These radicals are produced during normal cellular metabolism but can cause significant damage to DNA, proteins, and lipids if not neutralised. SOD helps maintain cellular integrity by reducing this damage, supporting overall health and longevity. Given its role in protecting cell damage, SOD has been utilised in skincare products, cosmeceuticals, dietary supplements, medical and therapeutic products as well as functional foods. Current methods to produce SOD include natural extraction from plants, microbial fermentation and recombinant DNA technology. However, challenges such as low yield, variation in quality and concentration, high costs and regulatory issues still remain. The technology owner uses specific strains of microorganism and advanced biotechnology processes to produce SOD at high yields via fermentation in a sustainable and efficient manner. The enzyme is then extracted and concentrated during downstream processing. This technology could ensure a consistent and scalable supply of SOD for commercial use. The company is seeking collaborations with skincare brands and cosmetic manufacturers interested in co-developing or licensing the technology for mass-market production and distribution.

Graphene-based antibacterial composite materials are a class of materials that combine graphene's unique properties with antibacterial agents to create surfaces or textiles that can effectively kill or inhibit the growth of bacteria. With its inherent antibacterial properties, graphene’s large surface area and high conductivity makes it an ideal carrier for functional molecules that exhibit antibacterial properties naturally. The technology on offer is a proprietary process to prepare and application of a green and multifunctional graphene-based antibacterial composite material for textiles. These materials can be applied to various textile materials and products, possessing antibacterial, antiviral, and deodorizing properties. Featuring high efficiency (99%), broad-spectrum coverage, non-toxicity, functionalised textiles can be used in healthcare and consumer products for long-lasting and multifunctional antibacterial properties. It is non-leaching and more eco-friendly compared to traditional chemical antibacterial products. This technology can endow textile products with antibacterial, antiviral, and deodorizing properties, enhancing the added value of traditional textile materials for safe and non-toxic antibacterial performance. The technology owner is interested in joint R&D projects with companies looking to incorporate this graphene-based antibacterial composite and develop new eco-friendly and multifunctional antibacterial textile products.  

With the global population rapidly aging, the prevalence of dementia is becoming an increasing concern. As more elderly individuals suffer from cognitive decline, including memory loss and impaired daily functioning, the need for effective interventions is urgent. Dementia, a condition affecting many worldwide, not only diminishes the quality of life for patients but also places a heavy burden on caregivers and healthcare systems.  In response to these challenges, this solution offers a novel method to help dementia patients maintain cognitive function through engaging therapeutic activities. The solution is a cognitive stimulation system that leverages motion tracking and multi-sensory feedback to help users recall familiar actions from their daily lives. By recreating activities such as ironing or spreading jam, the device taps into procedural memory, allowing users to re-enact tasks they once performed regularly. This process stimulates recollection, helping to evoke personal memories and improve cognitive agility. The technology owner is interested to work with:  (1) companies to co-develop/ out-license the technology to help serve more patients and elderly; (2) healthcare facilities such as hospitals or nursing homes for validations and trials. 

Diabetic foot ulcers (DFUs) are a serious and common complication of diabetes, often leading to infections, amputations, and prolonged hospitalizations. Even with current standard of care, treatment of DFUs is still challenging, and may not always prevent severe outcomes. This therapy system integrates advanced wound management techniques, focusing on enhancing wound healing, off-loading pressure from vulnerable areas, and improving infection control. Traditional treatments lack comprehensive solutions for wound healing enhancement, pressure off-loading, and effective infection control. This therapy system combines these features into a single solution, offering accelerated healing while its integrated disinfection mechanism helps manage infections with ease. The therapy system is efficient and user-friendly, suitable for deployment in various healthcare settings. Ideal collaboration partners include medical device manufacturers, wound care specialists, and healthcare institutions focused on innovative treatment solutions.